← FDA Drug Approvals (Drugs@FDA)

NEO-FRADIN

ANDA · Abbreviated New Drug Application (Generic) · Sponsor: X GEN PHARMS · Approved 2002-05-23

Drug application

FDA Application #

ANDA065010

Application type

Abbreviated New Drug Application (Generic)

Brand name

NEO-FRADIN

Generic name

Neomycin Sulfate

Active ingredients

NEOMYCIN SULFATE

Dosage form

SOLUTION

Route

ORAL

Marketing status

Discontinued

Sponsor

X GEN PHARMS

First approval

2002-05-23

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown